Financhill
Back

Accuray Quote, Financials, Valuation and Earnings

Accuray Price Quote

$1.79

Accuray Key Stats

Sell
37
Accuray (ARAY) is a Sell

Day range:
$1.76 - $1.85
52-week range:
$1.40 - $3.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.40
P/B ratio:
3.98%

Volume:
405.5K
Avg. volume:
686.7K
1-year change:
-36.97%
Market cap:
$180M
Revenue:
$446.6M
EPS:
$-0.17

How Much Does Accuray Make?

Data Unavailable

Is Accuray Growing As A Company?

Data Unavailable

Accuray Stock Price Performance

  • Did Accuray Stock Go Up Last Month?
    Accuray share price went down by -2.72% last month
  • Did ARAY's Share Price Rise Over The Last Year?
    ARAY share price fell by -36.97% over the past 1 year

What Is Accuray 52-Week High & Low?

  • What Is Accuray’s 52-Week High Share Price?
    Accuray has traded as high as $3.05 over the past 52 weeks
  • What Is Accuray’s 52-Week Low Share Price?
    Accuray has traded as low as $1.40 over the past 52 weeks

Accuray Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Accuray?

Data Unavailable

Is Accuray Cash Flow Positive?

Data Unavailable

Accuray Return On Invested Capital

Data Unavailable

Accuray Earnings Date & Stock Price

  • What Is Accuray's Stock Price Today?
    A single share of ARAY can be purchased today for 1.79
  • What Is Accuray’s Stock Symbol?
    Accuray trades on the nasdaq under the ticker symbol: ARAY
  • When Is Accuray’s Next Earnings Date?
    The next quarterly earnings date for Accuray is scheduled on January 31, 2025
  • When Is ARAY's next ex-dividend date?
    Accuray's next ex-dividend date is December 20, 2024
  • How To Buy Accuray Stock?
    You can buy Accuray shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Accuray Competitors

  • Who Are Accuray's Competitors?
    Below is a list of companies who compete with Accuray or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Accuray Dividend Yield

Data Unavailable

Accuray Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 38.46%
Revenue: -2.26% 4.09%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable